Ethambutol Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Ethambutol Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

ETHAMBUTOL HYDROCHLORIDE DESCRIPTION


Ethambutol Hydrochloride




CLINICAL PHARMACOLOGY




ANIMAL PHARMACOLOGY & OR TOXICOLOGY



INDICATIONS & USAGE


  • ●     Ethambutol Hydrochloride Tablets plus isoniazid
  • ●     Ethambutol Hydrochloride Tablets plus isoniazid plus streptomycin.


ETHAMBUTOL HYDROCHLORIDE CONTRAINDICATIONS



WARNINGS

PRECAUTIONSADVERSE REACTIONS
ADVERSE REACTIONS

PRECAUTIONS



ADVERSE REACTIONS


DRUG INTERACTIONS



PREGNANCY





NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE



ETHAMBUTOL HYDROCHLORIDE ADVERSE REACTIONS








WARNINGS
www.fda.gov/medwatch <%0A%09%09%09%09%09%09%09>

DOSAGE & ADMINISTRATION




Initial Treatment:


Retreatment:






HOW SUPPLIED


  • ●     Bottles of 100 tablets.

  • ●     Bottles of 60 tablets.
  • ●     Bottles of 90 tablets.
  • ●     Bottles of 100 tablets.
  • ●     Bottles of 1000 tablets.
  • ●     Unit Dose Boxes of 100 tablets.

STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Ethambutol Hydrochloride

Ethambutol Hydrochloride

Ethambutol Hydrochloride

Ethambutol Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-446(NDC:61748-014)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ETHAMBUTOL HYDROCHLORIDE ETHAMBUTOL 400 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
STARCH, CORN
CROSCARMELLOSE SODIUM
DOCUSATE SODIUM
lactose monohydrate
MAGNESIUM STEARATE
POVIDONE K30
STEARIC ACID
raw sugar
polyethylene glycol
polysorbate 80
titanium dioxide
HYPROMELLOSE 2208 (15000 MPA.S)

Product Characteristics

Color Size Imprint Code Shape
white 13 mm VP;14 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-446-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075095 2011-08-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.